GKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve Audited Standalone and Consolidated ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GKB Ophthalmics Ltd has informed BSE that its Board of Directors will meet on Friday, May 30, 2025, at the registered office in Mapusa, Goa. The key agenda is to consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and full year ended March 31, 2025. The trading window for designated persons has been closed since April 1, 2025, and will reopen 48 hours after the financial results are filed with the stock exchange. This is a routine advance intimation under SEBI listing regulations.
No immediate impact on shareholders or stock price — this is a standard pre-result announcement. Investors should watch for the actual audited numbers on or after May 30, 2025, which will reveal the company's full-year performance.